Clinicopathologic analysis of benign and malignant ovarian goiter
10.3969/j.issn.1007-3969.2013.07.008
- VernacularTitle:良、恶性卵巢甲状腺肿临床病理分析
- Author:
Song QING
;
Xiaohong LI
;
Na MIAO
;
Xia LIU
;
Yuqing MA
;
Wei ZHANG
- Publication Type:Journal Article
- Keywords:
Struma ovarii;
Differential diagnosis;
Prognosis;
Immunohistochemistry;
PCR-DNA
- From:
China Oncology
2013;(7):524-529
- CountryChina
- Language:Chinese
-
Abstract:
Background and purpose:Struma ovarii is a rare tumor, especially with extraovarian spreading. The study aimed to investigate the clinical and pathological features, diagnosis and differential diagnosis of ovarian goiter. Methods:Clinical and pathological features of 14 cases of benign and malignant ovarian goiter were observed. Immunohistochemical EnVision staining, PCR-DNA sequencing and review of related literature were also used. Results:In 14 cases of benign and malignant ovarian goiter, the average age of onset is 45.6 years (18-71 years old), and pelvic tumor is the main clinical manifestation. According to the related literature of diagnostic criteria, 12 cases are struma ovarii, which is consisted of hyperplasia of the thyroid tissue under microscopic examination, 1 case is malignant struma ovarii, which is papillary thyroid carcinoma by microscopic presentation, and 1 case is highly differentiated follicular carcinoma of ovarian origin (HDFCO), which is histological benign by microscopic presentation, but is malignant by biological behavior. Conclusion:Struma ovarii is a rare ovarian mondemal teratoma, with low rate of malignant change and beyond ovarian lesions disseminated microscopic histological benign struma ovarii is lower incidence, which has unique clinical and pathological features. Comprehensively considering the related literatures, this study indicates that the disease is in accordance with HDFCO. Struma ovarii prognosis is good, and should be differentiated from carcinoid and granular cell tumor.
